The FoxO–BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress
暂无分享,去创建一个
E. Lam | L. Zhuang | B. Gan | J. Yao | D. Wang | Zhuang Li | A. Lin | J. Han | Eric Lam | Aifu Lin | Jun Yao | Dingzhi Wang | Jiahuai Han | Boyi Gan
[1] Sang Gyun Kim,et al. Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. , 2013, Molecular cell.
[2] O. Kirak,et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival , 2012, Nature.
[3] H. Düssmann,et al. Two-step activation of FOXO3 by AMPK generates a coherent feed-forward loop determining excitotoxic cell fate , 2012, Cell Death and Differentiation.
[4] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[5] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[6] Lara J. Monteiro,et al. Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin* , 2011, The Journal of Biological Chemistry.
[7] R. Shaw,et al. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.
[8] Jiahuai Han,et al. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy depletion-induced suppression of mTORC1 , 2010, Nature Cell Biology.
[9] Gerald C. Chu,et al. FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis. , 2010, Cancer cell.
[10] L. Chin,et al. LKB1 regulates quiescence and metabolic homeostasis of hematopoietic stem cells , 2010, Nature.
[11] Sang Gyun Kim,et al. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. , 2010, Molecular cell.
[12] N. Hay,et al. FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. , 2010, Developmental cell.
[13] Shikha Khatri,et al. FOXO3a Regulates Glycolysis via Transcriptional Control of Tumor Suppressor TSC1* , 2010, The Journal of Biological Chemistry.
[14] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[15] Ji Zhang,et al. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy , 2009, Cell Death and Differentiation.
[16] J. Blenis,et al. Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.
[17] B. Rini,et al. Renal cell carcinoma , 2009, The Lancet.
[18] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[19] S. Gibson,et al. The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death , 2009, Cell Death and Differentiation.
[20] David A. Williams,et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization , 2008, Proceedings of the National Academy of Sciences.
[21] S. Gibson,et al. BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions , 2008, Oncogene.
[22] B. Manning,et al. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.
[23] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[24] A. Brunet,et al. The FoxO code , 2008, Oncogene.
[25] M. You,et al. Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with Rheb* , 2007, Journal of Biological Chemistry.
[26] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[27] S. Gygi,et al. The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.
[28] G. Thomas,et al. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.
[29] B. Burgering,et al. Stressing the role of FoxO proteins in lifespan and disease , 2007, Nature Reviews Molecular Cell Biology.
[30] Yonghong Xiao,et al. FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.
[31] B. Viollet,et al. 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments , 2006, Molecular and Cellular Biology.
[32] L. Cantley,et al. Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.
[33] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[34] N. Sonenberg,et al. Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity* , 2005, Journal of Biological Chemistry.
[35] K. Guan,et al. Identification of FIP200 interaction with the TSC1–TSC2 complex and its role in regulation of cell size control , 2005, The Journal of cell biology.
[36] W Marston Linehan,et al. Focus on kidney cancer. , 2004, Cancer cell.
[37] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[38] R. DePinho,et al. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. , 2004, Genes & development.
[39] D. Accili,et al. FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.
[40] Lewis C Cantley,et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[42] Ronald A. DePinho,et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation , 2002, Nature.
[43] Hongbing Zhang,et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.
[44] Tetsuo Noda,et al. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] H. Onda,et al. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. , 1999, The Journal of clinical investigation.
[46] K. Inoki,et al. TSC2: filling the GAP in the mTOR signaling pathway. , 2004, Trends in biochemical sciences.